2013 Publications – Cardiovascular Medicine

  1. Abbas AE, Franey LM, Marwick T, Maeder MT, Kaye DM, Vlahos AP, Serra W, Al-Azizi K, Schiller NB, Lester SJ. Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr. 2013;26(10):1170-7.
  2. Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, Reid CM, Golledge J, Kingwell BA. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA. 2013;309(5):453-60.
  3. Ariyaratne TV, Ademi Z, Duffy SJ, Andrianopoulos N, Billah, B, Brennan AL, New G, Black A, Ajani AE, Clark DJ, Yan BP, Yap C-H, Reid CM. Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry. International J Cardiol. 2013;168:2783-90.
  4. Byrne MJ, Idrizi R, Power JM, Kaye DM. Percutaneous re-circulating isolated limb perfusion of gentamicin in a large animal model: targeted delivery of gentamicin to limb. Am J Transl Res. 2013;5(1):47-52.
  5. Cameron JD, Dart AM. Misclassification of studies in 'Brachial artery tonometry and the Popeye phenomenon'. J Hypertens. 2013;31(1):208.
  6. Camuglia AC, Maeder MT, Starr J, Farrington C, Kaye DM. Impact of N-acetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomized controlled trial. Heart Lung Circ. 2013;22(4):256-9.
  7. Carey AL, Formosa MF, Van Every B, Bertovic D, Eikelis N, Lambert GW, Kalff V, Duffy SJ, Cherk MH, Kingwell BA. Ephedrine activates brown adipose tissue in lean but not obese humans. Diabetologia. 2013;56(1):147-55.
  8. Chan W, White DA, Wang X-Y, Bai R-F, Liu Y, Yu H-Y, Zhang Y-Y, Fan F, Schneider HG, Duffy SJ, Taylor AJ, Du X-J, Gao W, Gao X-M, Dart AM. Macrophage migration inhibitory factor for the early prediction of infarct size. J Am Heart Assoc. 2013;2(5):e000226.
  9. Ellims AH, Pfluger H, Elsik M, Butler MJ, Hare JL, Taylor AJ. Utility of cardiac magnetic resonance imaging, echocardiography and electrocardiography for the prediction of clinical response and long term survival following cardiac resynchronisation therapy. Int J Cardiovasc Imaging. 2013;29(6):1303-11.
  10. Ellims AH, Iles LM, Taylor AJ. Re: "Myocardial Tissue Characterization Using Magnetic Resonance Noncontrast T1 Mapping in Hypertrophic and Dilated Cardiomyopathy". [Letter]. Circ Cardiovasc Imaging. 2013;6(2):e1.
  11. Ellims AH, Mariani JA, Schlaich MP. Restoration of blood pressure control with pacemaker implantation in a patient with bradycardia and resistant hypertension: a case report. Int J Cardiol. 2013;167(2):e38-40.
  12. Fang L, Beale A, Ellims AH, Moore X-L, Ling L-H, Taylor AJ, Chin-Dusting J, Dart AM. The association between fibrocytes and post-contrast myocardial T1 time in hypertrophic cardiomyopathy. J Am Heart Assoc. 2013;2(5):e000270.
  13. Herring D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61(2):457-464.
  14. Heck PM, Lee JM, Kistler PM. Atrial fibrillation in heart failure in the older population. Heart Failure Clinics. 2013;9(4):451-9, viii–ix.
  15. Iles L, Taylor AJ. T1 mapping in myocarditis – is one better than two? (Editorial). JACC Cardiovasc Imaging. 2013;6(10):1059-1061.
  16. Iles L, Taylor AJ. Re: Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume [Letter]. Circ Cardiovasc Imaging. 2013;6:e25.
  17. Jaworski C, Looi JL, Martin J, Bergin P, Hare JL., Kaye D, Wei A, Taylor AJ. Cardiac Imaging in FIP1L1-PDGFRA. J Am Coll Cardiol. 2013;62(14):1304.
  18. Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol. 2013;61(23):2319-28.
  19. Kaye DM, Khammy O, Mariani J, Maeder MT. Relationship of circulating matrix biomarkers to myocardial matrix metabolism in advanced heart failure. Eur J Heart Fail. 2013;15(3):292-8.
  20. Kumar S, Haqqani HM, Chan M, Lee J, Yudi M, Wong MC, Morton JB, Ling LH, Robinson T, Heck PM, Kelland NF, Halloran K, Spence SJ, Kistler PM, Kalman JM. Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm. 2013;10(7):962–969.
  21. Kumar S, Walters TE, Halloran K, Morton JB, Hepworth G, Wong CX, Kistler PM, Sanders P, Kalman JM. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia. Europace. 2013;15(12):1702–1709.
  22. Lim HS, Stub D, Ajani AE, Andrianopoulos N, Reid CM, Charter K, Black A, Smith K, New G, Chan W, Lim CC, Farouque O, Shaw J, Brennan A, Duffy SJ, Clark DJ. Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention. International J Cardiol. 2013;166(2):425-30.
  23. Lim HS, Willoughby SR, Schultz C, Gan C, Alasady M, Lau DH, Leong DP, Brooks AG, Young GD, Kistler PM, Kalman JM, Worthley MI, Sanders P. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. JACC. 2013;61(8):852-860.
  24. Ling L-H, Kalman J, Ellims A, Iles L, Medi C, Sherratt C, Kaye D, Hare J, Kistler P, Taylor AJ. Diffuse Ventricular Fibrosis is a Late Outcome of Tachycardia-Mediated Cardiomyopathy Following Successful Ablation. Circ: Arrhythm Electrophysiol. 2013;6(4):697-704.
  25. Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013;10(9):1334-9.
  26. Lumsden NG, Andrews Kl, Bobadilla M, Moore XL, Sampson AK, Shaw JA, Mizrahi J, Kaye DM, Dart AM, Chin-Dusting JPF. Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome. Diab Vasc Dis Res. 2013;10(4):368-74.
  27. McLellan AJ, Kistler PM. Periesophageal Vagal Nerve Injury Post AF Ablation: the Esophagus a Vulnerable Neighbour? J Cardiovasc Electrophysiol. 2013;24(8):852-4.
  28. McLellan AJ, Schlaich MP. Dabigatran elimination: is hemodialysis effective? Thrombosis Haemost. 2013;109(4):580-1. Editorial.
  29. McLellan AJ, Kumar S, Smith C, Morton JB, Kalman JM, Kistler PM. The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: A systematic review. J Cardiovasc Electrophysiol. 2013;24(7):742-751.
  30. Medi C, Evered L, Silbert B, Teh A, Halloran K, Morton J, Kistler P, Kalman J. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2013;62(6):531–539.
  31. Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Juni P, PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083-1091.
  32. Moore XL, Michell D, Lee S, Skilton MR, Nair R, Dixon JB, Dart AM, Chin-Dusting J. Increased carotid intima-media thickness and reduced distensibility in human class III obesity: independent and differential influences of adiposity and blood pressure on the vasculature. PLOS ONE. 2013;8(1):e53972.
  33. Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J Nutr. 2013;110(12):2242-9.
  34. Prabhu S, McLellan AJ, Voskoboinik A, Kistler PM. Novel uses of Imaging in AF Ablation. Recent Pat Cardiovasc Drug Discov. 2013;8(2):93-111. Review.
  35. Rajapakse NW, Chong AL, Zhang WZ, Kaye DM. Insulin-mediated activation of the L-arginine nitric oxide pathway in man, and its impairment in diabetes. PLoS One. 2013;8(5):e61840.
  36. Reid Cm, Yan B, Wan Ahmad WA, Bang LH, Hian SK, Chua T, Chan M, Beltrame J, Duffy SJ, Brennan A, Ajani A. The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration-improving the quality of cardiovascular care in the Asia Pacific region. In J Cardiol. 2013;172(1):72-5.
  37. Rose H, Low H, Dewar E, Bukrinsky M, Hoy J, Dart A, Sviridov D. The Effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study. Atherosclerosis. 2013;229(1):206-211.
  38. Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler MD. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013;168(3):2214-20.
  39. Siebel AL, Natoli AK, Yap FY, Carey AL, Reddy-Luthmoodoo M, Sviridov D, Weber CI, Meneses-Lorente G, Maugeais C, Forbes JM, Kingwell BA. Effects of high-density lipoprotein elevation with cholesteryl ester transfer protein inhibition on insulin secretion. Circ Res. 2013;113(2):167-75.
  40. Stub D, Byrne M, Pellegrino V, Kaye DM. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in a sheep model of refractory ischaemic cardiac arrest. Heart Lung Circ. 2013;22(6):421-7.
  41. Taylor AJ, Ellims A, Lew PJK, Murphy B, Pally S, Younie S. Impact of cardiac magnetic resonance imaging on cardiac device and surgical therapy – a prospective study. Int J Cardiovasc Imaging. 2013;29(4):855-864.
  42. Van Empel VP, Kaye DM. Integration of exercise evaluation into the algorithm for evaluation of patients with suspected heart failure with preserved ejection fraction. Int J Cardiol. 2013;168(2):716-22.
  43. White DA, Fang KL, Chan W, Kiriazis H, Duffy SJ, Taylor A, Dart AM, Du X-J. Pro-inflammatory action in MIF in acute myocardial infarction via activation of peripheral blood mononuclear cells. PLOS One. 2013;8(10):e76206.
  44. Wong MC, Kalman JM, Ling LH, Medi C, Teh A, Lee G, Kumar S, Morton JB, Kistler PM. Left septal atrial tachycardias: electrocardiographic and electrophysiologic characterization of a paraseptal focus. J Cardiovasc Electrophysiol. 2013;24(4):413–418.
  45. Zurek M, Maeder MT, Brutsche MH, Christ A, Bosshard P, Ziller R, Rickli H, Kaye DM, Mueller C. Does hypoxemia have an impact on the cardiac release and circulating concentrations of natriuretic peptides in humans in vivo? Int J Cardiol. 2013;167(3):1046-8.

I am a PATIENT

i-am-a-patient

Consultation in the Heart Centre is only by referral from a Medical Practitioner.

I am a HEALTH PROFESSIONAL

i-am-a-health-professional

Please follow the link to find further information

Your STORIES

our-stories-home

‘This just doesn’t happen to people like me.’  aged 50...

Support US

the-alfred-foundation

Donate or Volunteer for research study. See how you can help.

Copyright © Alferd Health Victoria 2013 | Login